Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Anmol Cheema"'
Autor:
Ravneet Bajwa, John A. DePalma, Taimoor Khan, Anmol Cheema, Sheila A. Kalathil, Mohammad A. Hossain, Attiya Haroon, Anne Madhurima, Min Zheng, Ali Nayer, Arif Asif
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 8, Iss 1, Pp 25-34 (2018)
The advances in our understanding of the alternative pathway have emphasized that uncontrolled hyperactivity of this pathway causes 2 distinct disorders that adversely impact the kidney. In the so-called atypical hemolytic uremic syndrome (aHUS), ren
Externí odkaz:
https://doaj.org/article/5dbb434f7b5542b6a0fab24a1438724d
Autor:
Mohammad A Hossain, Anmol Cheema, Sheila Kalathil, Ravneet Bajwa, Eric J Costanzo, James Cosentino, Jennifer Cheng, Tushar Vachharajani, Arif Asif
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 29, Iss 2, Pp 276-283 (2018)
Atypical hemolytic uremic syndrome (aHUS) is characterized by microangiopathic hemolytic anemia, consumptive thrombocytopenia, and widespread damage to multiple organs including the kidney. The syndrome has a high mortality necessitating the need for
Externí odkaz:
https://doaj.org/article/25245ce8d448406c90941d88c405513e
Autor:
Shrinil Patel, Saira Chaughtai, Tejas Patel, Ravneet Bajwa, Alireza Amirpour, Mohammad A. Hossain, Arif Asif, Michael R. Levitt, Taimoor Khan, Varsha Gupta, Anmol Cheema, Joshua Bramson, Anju Paul
Publikováno v:
Journal of Clinical Medicine Research
In recent years the use of immunomodulating therapy to treat various cancers has been on the rise. Three checkpoint inhibitors have been approved by the Food and Drug Administration (ipilimumab, pembrolizumab and nivolumab). The use of these drugs co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0c113405ffc8aa7cce3c602a014128
http://europepmc.org/articles/PMC6436564
http://europepmc.org/articles/PMC6436564
Autor:
Ali Nayer, Arif Asif, Attiya Haroon, John A. Depalma, Sheila A. Kalathil, Min Zheng, Ravneet Bajwa, Anne Madhurima, Mohammad A. Hossain, Anmol Cheema, Taimoor Khan
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 8, Iss 1, Pp 25-34 (2018)
Case Reports in Nephrology and Dialysis
Case Reports in Nephrology and Dialysis
The advances in our understanding of the alternative pathway have emphasized that uncontrolled hyperactivity of this pathway causes 2 distinct disorders that adversely impact the kidney. In the so-called atypical hemolytic uremic syndrome (aHUS), ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca9875e5cb26334e5302e620978e3651
https://doi.org/10.1159/000486848
https://doi.org/10.1159/000486848
Publikováno v:
World Journal of Oncology
The utility of immunotherapy, such as pembrolizumab, is becoming essential in the treatment of certain cancers. Pembrolizumab works through binding of programmed cell death 1 receptor that blocks the binding of the programmed cell death ligand 1 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9724bb4eb6e97f4476cd90ee4aa9d631
https://doi.org/10.14740/wjon1085w
https://doi.org/10.14740/wjon1085w
Autor:
Anmol Cheema, Huzaif Qaisar, Arif Asif, Shreya Gor, Alireza Amirpour, Diana Curras-Martin, Mohammad A. Hossain, Avais Masud
Publikováno v:
Clinical Case Reports and Reviews. 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff851316413958594ed123b9d32e69c7
https://doi.org/10.15761/ccrr.1000443
https://doi.org/10.15761/ccrr.1000443
Publikováno v:
Journal of Clinical Oncology. 38:e16003-e16003
e16003 Background: Genomic instability from 20q amplification is an oncogenic pathway in colorectal cancer (CRC). Several genes have been implicated, including BCL2L1, AURKA, SRC, ASXL1, GNAS and TOP1. There is a lack of data regarding 20q amplified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e625e6e0f336fac1dce3273a9d0e00a0
https://doi.org/10.1200/jco.2020.38.15_suppl.e16003
https://doi.org/10.1200/jco.2020.38.15_suppl.e16003
Publikováno v:
Journal of Clinical Oncology. 38:e15148-e15148
e15148 Background: Immune-related adverse events (irAEs) due to immune checkpoint inhibitors (ICIs) are caused by non-specific immune system activation and develop in 30-70% of patients. The goal of this study is to examine the association of race wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::135c3c473cb03974aeee1548e54f0c4c
https://doi.org/10.1200/jco.2020.38.15_suppl.e15148
https://doi.org/10.1200/jco.2020.38.15_suppl.e15148
Autor:
Huzaif, Qaisar, Mina, Shenouda, Mohammed, Shariff, Anmol, Cheema, Xiaoyin, Tang, Adam, Kaplan
Publikováno v:
Archives of Iranian medicine. 22(7)
Granulomatosis with polyangiitis (GPA) is a rare rheumatologic disease characterized by small to medium vessel vasculitis and inflammation within multiple organ systems. Majority of cases involve both upper and lower respiratory tracts but other orga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f1fd25685223a91f3a3ae69b6fce601f
https://pubmed.ncbi.nlm.nih.gov/31679385
https://pubmed.ncbi.nlm.nih.gov/31679385
Publikováno v:
BMJ Case Reports
Duplication of the inferior vena cava (DIVC) is an uncommon embryological anatomic phenomenon. We report a 63-year-old woman with extensive right leg deep vein thrombosis who required an IVC filter due to contraindications for anticoagulation, but wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911bd1dadb4b76347f16ac42a6734836
http://europepmc.org/articles/PMC5990095
http://europepmc.org/articles/PMC5990095